2022. BMI and TLC Influences Doxorubicin/Epirubicin Neoadjuvant Chemotherapy Response in Patients with Locally Advanced Breast Cancer. Majalah Kedokteran Bandung. 54, 4 (Dec. 2022), 221–227. DOI:https://doi.org/10.15395/mkb.v54n4.2797.